Dashboard
Manage Tickers

ARDT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Breaking Down Ardent Health: 4 Analysts Sh...
10/14/2025 14:02:32

Core News & Articles
Goldman Sachs Initiates Coverage On Ardent...
10/14/2025 12:50:18

Goldman Sachs analyst Scott Fidel initiates coverage on Ardent Health (NYSE:ARDT) with a Neutral rating and announces Price...

Core News & Articles
Breaking Down Ardent Health: 4 Analysts Sh...
09/10/2025 12:02:33

this-robinhood-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-wednesday
This Robinhood Analyst Begins Coverage On ...
09/10/2025 11:42:51

Core News & Articles
UBS Initiates Coverage On Ardent Health wi...
09/10/2025 10:47:14

UBS analyst A.J. Rice initiates coverage on Ardent Health (NYSE:ARDT) with a Buy rating and announces Price Target of $17.

Core News & Articles
Ardent Health Files For Mixed Shelf Of Up ...
08/21/2025 20:29:26

- SEC Filing

Core News & Articles
What 5 Analyst Ratings Have To Say About A...
08/11/2025 12:00:47

Core News & Articles
JP Morgan Maintains Neutral on Ardent Heal...
08/11/2025 10:12:29

JP Morgan analyst Benjamin Rossi maintains Ardent Health (NYSE:ARDT) with a Neutral and lowers the price target from $18 to ...

Core News & Articles
Keybanc Maintains Overweight on Ardent Hea...
08/07/2025 13:49:05

Keybanc analyst Matthew Gillmor maintains Ardent Health (NYSE:ARDT) with a Overweight and lowers the price target from $24 t...

Core News & Articles
Ardent Health Affirms FY2025 GAAP EPS Guid...
08/05/2025 20:32:25

Ardent Health (NYSE:ARDT) affirms FY2025 GAAP EPS guidance from $1.73-$2.01 to $1.73-$2.01 vs $1.92 analyst estimate. Affirms F...

Core News & Articles
Ardent Health Partners Q2 EPS $0.52, Inlin...
08/05/2025 20:31:03

Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. Thi...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/16/2025 17:06:26

4-analysts-have-this-to-say-about-ardent-health
4 Analysts Have This To Say About Ardent H...
07/16/2025 12:02:02

Core News & Articles
B of A Securities Downgrades Ardent Health...
07/16/2025 11:40:43

B of A Securities analyst Kevin Fischbeck downgrades Ardent Health (NYSE:ARDT) from Neutral to Underperform and lowers the p...

Core News & Articles
Ardent Health Partners Changes Name To Ard...
05/23/2025 20:33:04

Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare i...

Core News & Articles
Stephens & Co. Reiterates Overweight on Ar...
05/20/2025 12:51:38

Stephens & Co. analyst Scott Fidel reiterates Ardent Health Partners (NYSE:ARDT) with a Overweight and maintains $21 pr...

Core News & Articles
RBC Capital Reiterates Outperform on Arden...
05/15/2025 15:59:35

RBC Capital analyst Ben Hendrix reiterates Ardent Health Partners (NYSE:ARDT) with a Outperform and maintains $21 price target.

expert-outlook-ardent-health-partners-through-the-eyes-of-7-analysts
Expert Outlook: Ardent Health Partners Thr...
05/09/2025 21:00:20

Core News & Articles
Guggenheim Maintains Buy on Ardent Health ...
05/09/2025 16:28:35

Guggenheim analyst Jason Cassorla maintains Ardent Health Partners (NYSE:ARDT) with a Buy and raises the price target from $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION